D H Abramson

Summary

Publications

  1. ncbi request reprint Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival
    David H Abramson
    Robert M Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    Pediatrics 112:1248-55. 2003
  2. ncbi request reprint Optic nerve tissue shrinkage during pathologic processing after enucleation for retinoblastoma
    David H Abramson
    Department of Ophthalmology, New York Presyterian Hospital Weill Medical College of Cornell University, New York, NY, USA
    Arch Ophthalmol 121:73-5. 2003
  3. ncbi request reprint Rapid growth of retinoblastoma in a premature twin
    David H Abramson
    Arch Ophthalmol 120:1232-3. 2002
  4. pmc Systemic carboplatin for retinoblastoma: change in tumour size over time
    D H Abramson
    70 East 66th Street, New York, NY 10021, USA
    Br J Ophthalmol 89:1616-9. 2005
  5. ncbi request reprint Update on retinoblastoma
    David H Abramson
    Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Retina 24:828-48. 2004
  6. ncbi request reprint Successful treatment of metastatic retinoblastoma
    I J Dunkel
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 89:2117-21. 2000
  7. doi request reprint Orbital recurrence of retinoblastoma following enucleation
    J W Kim
    Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Br J Ophthalmol 93:463-7. 2009
  8. ncbi request reprint Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization
    M A Klufas
    Department of Ophthalmology, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, USA
    AJNR Am J Neuroradiol 33:1608-14. 2012
  9. ncbi request reprint Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma
    D H Abramson
    Department of Ophthalmology, New York-Presbyterian Hospital, New York Weill Cornell Medical Center, New York, New York, USA
    Ophthalmology 108:1868-76. 2001
  10. ncbi request reprint Engraftment and growth of patient-derived retinoblastoma tumour in severe combined immunodeficiency mice
    Y Yan
    Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur J Cancer 36:221-8. 2000

Collaborators

Detail Information

Publications51

  1. ncbi request reprint Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival
    David H Abramson
    Robert M Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    Pediatrics 112:1248-55. 2003
    ..To correlate 3 common presenting signs of retinoblastoma with patient and ocular survival and to assess the efficacy of current pediatric screening practices for retinoblastoma...
  2. ncbi request reprint Optic nerve tissue shrinkage during pathologic processing after enucleation for retinoblastoma
    David H Abramson
    Department of Ophthalmology, New York Presyterian Hospital Weill Medical College of Cornell University, New York, NY, USA
    Arch Ophthalmol 121:73-5. 2003
    ..To quantify and analyze the differences between the length of the optic nerve as measured by the ophthalmologist in the operating room after enucleation and the length as measured by the pathologist after fixation...
  3. ncbi request reprint Rapid growth of retinoblastoma in a premature twin
    David H Abramson
    Arch Ophthalmol 120:1232-3. 2002
  4. pmc Systemic carboplatin for retinoblastoma: change in tumour size over time
    D H Abramson
    70 East 66th Street, New York, NY 10021, USA
    Br J Ophthalmol 89:1616-9. 2005
    ..Quantitative data regarding retinal tumour response following treatment with primary systemic carboplatin are reported...
  5. ncbi request reprint Update on retinoblastoma
    David H Abramson
    Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Retina 24:828-48. 2004
  6. ncbi request reprint Successful treatment of metastatic retinoblastoma
    I J Dunkel
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 89:2117-21. 2000
    ..In the current study, the authors evaluated the use of combined intensive conventional chemotherapy, high dose chemotherapy with autologous stem cell rescue (ASCR), and radiation therapy...
  7. doi request reprint Orbital recurrence of retinoblastoma following enucleation
    J W Kim
    Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Br J Ophthalmol 93:463-7. 2009
    ..To determine the incidence, clinical presentation and histopathological profile of patients developing orbital recurrence following enucleation for retinoblastoma...
  8. ncbi request reprint Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization
    M A Klufas
    Department of Ophthalmology, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, USA
    AJNR Am J Neuroradiol 33:1608-14. 2012
    ..The purpose of this work was to report our initial results with intra-arterial chemotherapy for intraocular retinoblastoma when delivery of the drug was not via direct catheterization of the OA...
  9. ncbi request reprint Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma
    D H Abramson
    Department of Ophthalmology, New York-Presbyterian Hospital, New York Weill Cornell Medical Center, New York, New York, USA
    Ophthalmology 108:1868-76. 2001
    ..The locations and expected ages at which additional tumors develop are consistent with the patterns we have seen in second tumors...
  10. ncbi request reprint Engraftment and growth of patient-derived retinoblastoma tumour in severe combined immunodeficiency mice
    Y Yan
    Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur J Cancer 36:221-8. 2000
    ..c. inoculation and suggest the possibility of using the SCID mouse model to study the intrinsic biological behaviour of human retinoblastoma and to develop novel therapeutic strategies in the treatment of this disease...
  11. ncbi request reprint Optic nerve involvement in retinoblastoma
    I Magramm
    Department of Ophthalmology, Manhattan Eye, Ear and Thorat Hospital, New York, NY 10021
    Ophthalmology 96:217-22. 1989
    ..Multivariate statistical analysis shows that the grade of optic nerve involvement and the age at diagnosis of optic nerve involvement are the factors most significantly associated with survival...
  12. ncbi request reprint An aggressive bone marrow evaluation including immunocytology with GD2 for advanced retinoblastoma
    Guillermo L Chantada
    Department of Hemato Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
    J Pediatr Hematol Oncol 28:369-73. 2006
    ..GD2 was intensively expressed and it may also be used to monitor disease response and the presence of minimal residual disease...
  13. ncbi request reprint Tobacco use in adult long-term survivors of retinoblastoma
    Meredith C Foster
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, EPS 7044, 6120 Executive Boulevard, Rockville, MD 20852, USA
    Cancer Epidemiol Biomarkers Prev 15:1464-8. 2006
    ..Smoking did not account for the increased risk of lung cancer among hereditary Rb patients, and this may point to an enhanced sensitivity to the carcinogenic effects of tobacco. Adult survivors of Rb should be encouraged to stop smoking...
  14. ncbi request reprint Growing melanocytic tumor is not always cancer
    David H Abramson
    Arch Ophthalmol 123:1457-8. 2005
  15. ncbi request reprint Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma
    Ruth A Kleinerman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, EPS 7044, 6120 Executive Blvd, Rockville, MD 20852, USA
    J Natl Cancer Inst 99:24-31. 2007
    ..Survivors of hereditary retinoblastoma have an increased risk for second malignancies, especially soft tissue sarcomas. However, the risks of individual histologic subtypes of soft tissue sarcomas have not been evaluated...
  16. ncbi request reprint Variates of survival in metastatic uveal melanoma
    Petra Rietschel
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 23:8076-80. 2005
    ..We evaluated the survival of our patients with metastatic uveal melanoma, described factors that correlated with survival, and evaluated the influence of screening tests on time of detection and survival...
  17. ncbi request reprint A phase II trial of carboplatin for intraocular retinoblastoma
    Ira J Dunkel
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Pediatr Blood Cancer 49:643-8. 2007
    ....
  18. ncbi request reprint Impairments in antifolate transport are common in retinoblastoma tumor samples
    Richard G Gorlick
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Pediatr Blood Cancer 50:573-6. 2008
    ..Identification of effective chemotherapy agents for retinoblastoma that are not associated with an elevated risk of secondary malignancy would be beneficial...
  19. ncbi request reprint Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?
    Dan S Gombos
    Section of Ophthalmology, Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas 77030, USA
    Ophthalmology 114:1378-83. 2007
    ..To describe a series of patients with secondary acute myelogenous leukemia (sAML) and retinoblastoma (RB)...
  20. ncbi request reprint Topotecan vitreous levels after periocular or intravenous delivery in rabbits: an alternative for retinoblastoma chemotherapy
    Angel M Carcaboso
    Departments of Pharmacology, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Buenos Aires, Argentina
    Invest Ophthalmol Vis Sci 48:3761-7. 2007
    ..To determine the extent and the mechanism by which topotecan, a candidate agent for the treatment of retinoblastoma, gains access to the vitreous when administered by periocular injection or intravenous infusion...
  21. ncbi request reprint Current management strategies for intraocular retinoblastoma
    Jonathan W Kim
    Department of Ophthalmic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Drugs 67:2173-85. 2007
    ..Therefore, modern centres treating retinoblastoma continue to manage patients with a variety of modalities, individualising the therapy according to the patient's presentation and clinical course...
  22. doi request reprint A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results
    David H Abramson
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ophthalmology 115:1398-404, 1404.e1. 2008
    ....
  23. pmc Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers
    Victoria Sheen
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland 20852, USA
    Cancer 113:434-41. 2008
    ..The aim of the current study was to investigate the pattern of cancer screening behavior in adult retinoblastoma survivors, who are at high risk of developing second cancers...
  24. ncbi request reprint The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?
    Allison E Rizzuti
    Arch Ophthalmol 126:862-5. 2008
  25. ncbi request reprint Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma
    Guillermo L Chantada
    Department of Hemato Oncology, Hospital JP Garrahan, Buenos Aires, Argentina, and Department of Pathology, University of Sao Paulo, Brazil
    Pediatr Blood Cancer 49:256-60. 2007
    ..To assess the outcome and determine risk factors for extraocular relapse in patients with retinoblastoma who had been enucleated after failure of chemoreduction...
  26. ncbi request reprint Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up
    Ruth A Kleinerman
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852 7362, USA
    J Clin Oncol 23:2272-9. 2005
    ..We have extended the follow-up of a large cohort of Rb patients for 7 more years to provide new information on the risk of additional cancers after radiotherapy in long-term survivors...
  27. ncbi request reprint Brain necrosis after enucleation, external beam cobalt radiotherapy, and systemic chemotherapy for retinoblastoma
    Gilbert D A Padula
    Department of Ophthalmology, Weill Medical College of Cornell University, New York, NY 10021, USA
    Arch Ophthalmol 120:98-9. 2002
  28. ncbi request reprint Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success
    David H Abramson
    Department of Ophthalmology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
    Ophthalmology 111:984-91. 2004
    ..To determine which small retinoblastoma tumors can be treated with transpupillary thermotherapy (TTT) alone and to clarify the minimum amount of treatment required to prevent recurrence...
  29. ncbi request reprint Metastatic ocular melanoma
    David H Abramson
    Arch Ophthalmol 122:658-9. 2004
  30. ncbi request reprint New retinoblastoma tumor formation in children initially treated with systemic carboplatin
    Thomas C Lee
    Department of Ophthalmology, New York Presbyterian Hospital Weill Medical College of Cornell University, 70 East 66th Street, New York, NY 10021, USA
    Ophthalmology 110:1989-94; discussion 1994-5. 2003
    ..To determine the frequency and timing of new intraocular tumor formation in children with hereditary retinoblastoma initially treated with systemic carboplatin...
  31. ncbi request reprint Bilateral retinoblastoma, microphthalmia, and colobomas in the 13q deletion syndrome
    Lisa S Schocket
    Scheie Eye Institute, University of Pennsylvania, Philadelphia 19104, USA
    Arch Ophthalmol 121:916-7. 2003
  32. ncbi request reprint Impact on survivors of retinoblastoma when informed of study results on risk of second cancers
    Charlene J Schulz
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Med Pediatr Oncol 41:36-43. 2003
    ..To assess the impact of providing research feedback to retinoblastoma survivors or their parents regarding the risk of second cancers...
  33. ncbi request reprint Osteogenic sarcoma in a survivor of metastatic germline retinoblastoma: the possible influence of human growth hormone
    David H Abramson
    New York Presbyterian Hospital, Weill Medical College, Cornell University, New York, USA
    J Pediatr Ophthalmol Strabismus 39:347-8. 2002
  34. ncbi request reprint (Neonatal) retinoblastoma in the first month of life
    David H Abramson
    Robert M Ellsworth Ophthalmic Oncology Center, New York Presbyterian Hospital Weill Cornell Medical College, NY, USA
    Arch Ophthalmol 120:738-42. 2002
    ..To identify patients with retinoblastoma whose conditions were diagnosed at the age of 1 month or younger and to describe their clinical features (including ocular and patient survival) and the development of second nonocular tumors...
  35. ncbi request reprint Delayed diagnosis of retinoblastoma: analysis of degree, cause, and potential consequences
    Linda J Butros
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Pediatrics 109:E45. 2002
    ..To assess the degree, cause, and consequence of delays from presenting signs to diagnosis of retinoblastoma...
  36. ncbi request reprint Chorioretinal scar growth after 810-nanometer laser treatment for retinoblastoma
    Thomas C Lee
    Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ophthalmology 111:992-6. 2004
    ..To determine the extent of expansion of laser scars after single treatment with transpupillary thermotherapy (TTT) for retinoblastoma...
  37. ncbi request reprint Periocular chemotherapy for retinoblastoma: success with problems?
    David H Abramson
    Arch Ophthalmol 123:128-9; author reply 129. 2005
  38. ncbi request reprint Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma
    David H Abramson
    Department of Ophthalmology, New York Presbyterian Hospital Weill Medical College of Cornell University, 70 E 66th Street, New York, NY 10021, USA
    Arch Ophthalmol 122:1316-23. 2004
    ..To describe patient and ocular outcomes following initial treatment with external beam radiotherapy (EBT) in eyes with Reese-Ellsworth group Vb retinoblastoma...
  39. ncbi request reprint Visual fields in retinoblastoma survivors
    David H Abramson
    Ophthalmology Oncology Service, Departments of Surgery, Radiation Oncology, and Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
    Arch Ophthalmol 122:1324-30. 2004
    ..To describe the visual field defects in retinoblastoma survivors and relate those defects to characteristics such as tumor size, tumor location, and treatment modality...
  40. ncbi request reprint Tadalafil-induced subretinal and choroidal hemorrhage in a patient with an unsuspected uveal (choroidal and ciliary body) melanoma
    David H Abramson
    Arch Ophthalmol 124:1058-60. 2006
  41. ncbi request reprint Fruit and vegetable intake during pregnancy and risk for development of sporadic retinoblastoma
    Manuela A Orjuela
    Department of Pediatrics, Mailman School of Public Health at Columbia University, Room B106, 60 Haven Avenue, New York, New York 10032, USA
    Cancer Epidemiol Biomarkers Prev 14:1433-40. 2005
    ..Fruits and vegetables are important sources of carotenoids and folate. We examined whether decreased gestational maternal intake of fruits and vegetables may contribute to development of sporadic retinoblastoma...
  42. ncbi request reprint High-dose supplements for age-related macular degeneration: did you leave out centrum?
    David H Abramson
    Arch Ophthalmol 120:1602. 2002
  43. ncbi request reprint Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture
    David H Abramson
    Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10023, USA
    Invest Ophthalmol Vis Sci 46:2683-91. 2005
  44. ncbi request reprint More aggressive bone marrow screening in retinoblastoma patients is not indicated: the memorial Sloan-Kettering cancer center experience
    Stergios Zacharoulis
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Pediatr Blood Cancer 46:56-61. 2006
    ....
  45. ncbi request reprint Treatment of choroidal melanoma using photodynamic therapy
    Irene A Barbazetto
    E S Harkness Eye Institute, New York Presbyterian Hospital, Columbia University, New York, New York 10032, USA
    Am J Ophthalmol 135:898-9. 2003
    ..To InternetAdvance publication at ajo.com Feb 26, 2002. investigate the effect of photodynamic therapy using verteporfin on choroidal melanoma...
  46. ncbi request reprint Microsatellite instability and MLH1 promoter methylation in human retinoblastoma
    Kwong Wai Choy
    Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Kowloon
    Invest Ophthalmol Vis Sci 45:3404-9. 2004
    ..To investigate the link between microsatellite instability and epigenetic silencing of the MLH1 gene in the human retinoblastoma genome...
  47. ncbi request reprint Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn
    Kangpu Xu
    Institute for Reproductive Medicine, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York 10021, USA
    Am J Ophthalmol 137:18-23. 2004
    ....
  48. pmc Rb induces a proliferative arrest and curtails Brn-2 expression in retinoblastoma cells
    David Cobrinik
    Margaret M, Dyson Vision Research Institute, Weill Medical College of Cornell University, New York, NY 10021, USA
    Mol Cancer 5:72. 2006
    ..Retinoblastoma is caused by loss of the Rb protein in early retinal cells. Although numerous Rb functions have been identified, Rb effects that specifically relate to the suppression of retinoblastoma have not been defined...
  49. ncbi request reprint Lack of activity of oral etoposide for relapsed intraocular retinoblastoma
    Ira J Dunkel
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ophthalmic Genet 25:25-9. 2004
    ..Because oral etoposide has been found to be highly effective in patients with relapsed medulloblastoma and neuroblastoma who had previously received intravenous etoposide, we investigated its use for intraocular retinoblastoma...
  50. ncbi request reprint Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells
    Jasmine R Elison
    Department of Ophthalmology, Weill Medical College of Cornell University, New York Presbyterian Hospital, 520 E 70th Street, New York, NY 10021, USA
    Arch Ophthalmol 124:1269-75. 2006
    ..To determine the efficacy of inducing p53-mediated cell death in retinoblastoma cells by Nutlin 3A, a small molecule HDM2 inhibitor...
  51. pmc Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma
    Kwong Wai Choy
    Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong, China
    Neoplasia 7:200-6. 2005
    ..Epigenetic mechanism plays an important role in the progression of retinoblastoma...